Want to join the conversation?
$ALXN reported today that its Biologics License Application (BLA) for Kanuma, an investigational enzyme replacement therapy for the treatment of lysosomal acid lipase deficiency, has received a PDUFA date extension from the FDA. It has got 3 months extension from the earlier reported Sept. 8, 2015 PDUFA date, and reiterating its guidance for 2015.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!